Dentroid
Dentroid is an Australian medical device startup developing Nuralyte™, a needle-free photonic analgesia device, and Dentroid-R, a femtosecond laser surgical platform, to deliver pain-free, drill-free dentistry to dental practitioners and needle-anxious patients globally.
- Company typePrivate
- Founded2017
- HeadquartersCanberra, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Dentroid does
Dentroid is an Australian medical device startup founded in 2017 by dentist Dr Omar Zuaiter and engineer Mr Alaa Habeb, developing a photonics- and robotics-based platform for pain-free dentistry. The company operates two core products: Nuralyte™, a needle-free photonic analgesia device that uses photobiomodulation to calm nociceptors and induce analgesia in under two minutes, and Dentroid-R, a femtosecond laser surgical device that ablates dental tissue via 'cold cutting' without needles, drills, intra-oral sprays, or thermal damage. Both technologies are integrated with miniaturised robotics and AI-assisted control, and the IP estate spans patents granted in 15 countries for Dentroid-R and an Australian grant plus second patent family for Nuralyte. The company is currently in pre-revenue clinical-trial stage, running a Stage 2 Nuralyte trial with 900+ patients across multiple Australian universities, with TGA and FDA regulatory verification still pending.
The business model is hardware sales of Nuralyte and Dentroid-R devices to dental practices and healthcare institutions, supplemented by licensing and co-commercialization revenue from a global partnership with Septodont (announced 5 June 2026). Go-to-market is enterprise field sales supported by clinical trial partnerships with the University of Queensland, Griffith University, and Australian National University, and global distribution leverage through Septodont's established dental pharmaceutical channels. Pricing is not publicly disclosed. Revenue to date has been limited to Australian government grants (Canberra Innovation Network pre-seed, ACT Government, AMGC, ARC, AEA), an oversubscribed 2018 seed round, and a $22.4M Septodont-linked round in June 2026. The company is headquartered in Canberra with an R&D facility in Queanbeyan, NSW, and operates with 11-50 employees.
Dentroid firmographics
Firmographics- Name
- Dentroid
- Legal name
- Dentroid Pty Ltd
- Website
- https://dentroid.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dentroid is an Australian medical device startup developing Nuralyte™, a needle-free photonic analgesia device, and Dentroid-R, a femtosecond laser surgical platform, to deliver pain-free, drill-free dentistry to dental practitioners and needle-anxious patients globally.
- Ownership category
- akta.pro rank
Dentroid industry classification
Industry- Product category
- Dental Medical Equipment
- NAICS
- Dental Equipment and Supplies Manufacturing (339114)
- SIC
- Dental Equipment & Supplies (3843), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Restorative General Dentistry (Fillings/Crowns/Bridges) (HLABAAAB)
- akta.pro secondary industries
- Dentoalveolar Surgery (Tooth Extractions & Alveoloplasty) (HLABAEAA), Fixed Prosthodontics (Crowns, Bridges, Veneers) (HLABAFAA)
Keywords
Where Dentroid is headquartered
LocationHeadquarters
- HQ city
- Canberra
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Dentroid business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Nuralyte™ Device Sales: Sale of the Nuralyte photonic analgesia device to dental practices and healthcare institutions. The device is designed for straightforward use in dental settings with no particular training required for dental staff. Technologies are still in development and pending regulatory verification by TGA and FDA.
- Dentroid-R Device Sales: Sale of the Dentroid-R femtosecond laser surgical device to dental practices. The device replaces traditional dental drills and rotary instruments, targeting premium dental care providers seeking pain-free treatment solutions.
- Licensing and Commercialization (Septodont Partnership): Global development and commercialization partnership with Septodont (announced June 2026) for non-invasive pain management in dentistry, representing a licensing and co-commercialization revenue stream across international markets.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Dentroid product offering
Product offeringCore offering
Dentroid develops and manufactures photonic and robotic medical devices for pain-free dentistry. Its core products are Nuralyte™, a needle-free analgesia device that uses photobiomodulation (gentle bursts of proprietary light wavelengths to calm pain nerves), and Dentroid-R, a femtosecond laser surgical device that enables needle-, spray-, and drill-free dental treatment using 'cold cutting' technology. Both devices target dental practices seeking to replace traditional needles, drills, and intra-oral sprays.
Product overview
Dentroid is developing a platform combining photonics and miniaturized robotics for pain-free dentistry, consisting of two main products: Nuralyte™ for needle-free pain management (analgesia/anesthesia using photobiomodulation) and Dentroid-R for precision dental treatment using femtosecond lasers. Together, these technologies aim to replace traditional needles, drills, and sprays with gentle light-based and robotic solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Nuralyte™ A photonic analgesia device using photobiomodulation (PBM) with proprietary blends of light wavelengths to interact with mitochondria in pain nerves (nociceptors), inducing dental analgesia in under 2 minutes lasting approximately 20 minutes after 60 seconds of exposure. Designed to replace or reduce the need for traditional numbing needles in routine dental procedures for dental practices and practitioners.
- Dentroid-R A femtosecond laser-based robotic dental surgical device that enables needle-, intra-oral spray-, and drill-free dental treatment using patented 'cold cutting' technology to precisely ablate dental hard tissue without thermal damage or cooling sprays, leaving underlying tissue pristine for faster healing with fewer postoperative complications. Targets dental practices and premium dental care providers seeking pain-free treatment solutions.
Quantifiable outcome
- Pre-emptive analgesia induced in human teeth in less than 2 minutes and lasting approximately 20 minutes after 60 seconds of Nuralyte™ light exposure
- +3 more outcomes
Companies that use Dentroid
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Dentroid technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Dentroid partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered flagship, core and minor.
- SeptodontflagshipGlobal development and commercialization partnership to pioneer non-invasive pain management in dentistry. Announced June 5, 2026 between Dentroid (Saint-Maur-des-Fossés, France and Canberra, Australia). Septodont is a major dental pharmaceutical company, making this a flagship partnership for international commercialization of Nuralyte™.
- Griffith UniversitycoreCollaborating on clinical trials for needle-free pain management technology. Joint press release (July 17, 2025) on new technology for accelerating healing and managing pain. Collaborators from Griffith include Prof Dzung Dao, Dr Peter Woodfield, Prof Roy George, and Dr Van Dau.
- University of Queensland (UQ)coreConducting Stage 2 clinical trials for Nuralyte involving 900+ patients. UQ press release (May 28, 2025) announced 'Pain-free, needle-free dentistry under clinical trial'. Represents a core clinical validation and early commercial pathway partner.
- Australia's Economic Accelerator (AEA)coreDentroid received the AEA Grant to support scaling of its technologies and progression toward commercialization.
- IMCRC (Innovative Manufacturing Cooperative Research Centre)coreResearch collaboration to develop laser for cutting-edge robotic dentistry. IMCRC provided $100,000 in funding support for the Dentroid-R femtosecond laser dental robot development.
- AMGC (Advanced Manufacturing Growth Centre)coreDentroid received a grant from AMGC in August 2020 to support the advancement of its advanced manufacturing capabilities for the dental laser technology.
- Canberra Innovation Network (CIN)coreDentroid won competitive pre-seed funding and acceleration from Canberra Innovation Network in May 2017. CIN is a foundational partner in Dentroid's early-stage development journey.
- Australian National University (ANU)coreResearch collaborator on femtosecond laser dentistry and photonic technology development. Collaborators include Prof Andrei Rode, Prof Steve Madden, and Dr Ludovic Rapp. ANU fabrication capabilities used for device development.
- ARC (Australian Research Council)coreDentroid received an ARC Grant (Australian Research Council) in 2022. Also mentioned $28 million in ARC Linkage grants awarded across the sector, with Dentroid as a recipient.
- Platypus Medtech ConsultingminorPartner providing medtech consulting services to support Dentroid's regulatory, clinical, and commercialization pathway planning.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Dentroid competitors and assessment
Company assessmentEmerging players
- CAO Group: US dental and medical device manufacturer specializing in diode lasers and cosmetic/photonic dental products. Comparable as a smaller specialist targeting similar practice-level device adoption.
Broad incumbents
- A-dec: Family-owned US dental equipment manufacturer (chairs, delivery systems, lights). Broad incumbent serving the same dental practice customer base as Dentroid's device buyers.
- Align Technology: Public medtech behind Invisalign and iTero scanners; a digital dentistry incumbent with comparable premium-practice positioning and technology-led disruption of traditional dental workflows.
- Straumann Group: Global dental implant and equipment leader serving premium dental practices. Comparable as a premium dental device incumbent with similar GTM to dental specialists.
- Dentsply Sirona: Largest dental equipment and consumables manufacturer globally (chairs, handpieces, CEREC CAD/CAM, imaging). Broad incumbent whose equipment Dentroid's photonic platform could complement or displace.
- Envista Holdings: Dental equipment and consumables parent company (Nobel Biocare, KaVo, Kerr). Broad incumbent with overlapping dental equipment portfolio and global distribution Dentroid could leverage or compete against.
Direct peers
- Fotona: Slovenian laser manufacturer (LightWalker, SkyPulse) used across dentistry, aesthetics, and surgery. Closely comparable to Dentroid's Er:YAG/femtosecond laser platform with overlapping dental applications.
- Convergent Dental: Private US dental laser company behind Solea (CO2 9.3µm laser) — a needle- and drill-free platform sold to dental practices. Direct competitor to Dentroid-R with overlapping value proposition and target customer.
- Biolase: US-listed dental laser company (Waterlase, Epic) selling erbium and diode lasers to dental practices for hard/soft tissue procedures. Directly comparable to Dentroid-R as a dental laser device vendor targeting needle- and drill-free workflows.
- Millennium Dental Technologies: Manufacturer of the PerioLase Nd:YAG laser used in the LANAP protocol for periodontics. Comparable as a niche dental laser specialist targeting specific clinical indications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Dentroid social profiles
Digital presenceDentroid financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dentroid leadership team
Management profileNumber of profiles
Profiles6 records
Dentroid funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dentroid M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dentroid
What does Dentroid do?
Dentroid develops and manufactures photonic and robotic medical devices for pain-free dentistry. Its core products are Nuralyte™, a needle-free analgesia device that uses photobiomodulation (gentle bursts of proprietary light wavelengths to calm pain nerves), and Dentroid-R, a femtosecond laser surgical device that enables needle-, spray-, and drill-free dental treatment using 'cold cutting' technology. Both devices target dental practices seeking to replace traditional needles, drills, and intra-oral sprays.
Is Dentroid a public or private company?
Dentroid is a private company. It is classified as venture growth investor backed and is currently operating.
When was Dentroid founded?
Dentroid was founded in 2017. It employs 11 to 50 people.
Where is Dentroid based?
Dentroid is headquartered in Canberra, Australia, in the Oceania region.
How does Dentroid make money?
Three revenue lines are on record. Nuralyte™ Device Sales are the primary driver. The others are dentroid-R Device Sales and licensing and Commercialization (Septodont Partnership).
Who are Dentroid's main competitors?
CAO Group is listed as an emerging player. Broad incumbents are A-dec, Align Technology, Straumann Group, Dentsply Sirona and Envista Holdings. Direct peers are Fotona, Convergent Dental, Biolase and Millennium Dental Technologies.
Does Dentroid have an API?
No public API is recorded for Dentroid.
What industry is Dentroid in?
Dentroid's product category is Dental Medical Equipment. Its primary akta.pro industry code is HLABAAAB, Restorative General Dentistry (Fillings/Crowns/Bridges), with a secondary code of HLABAEAA, Dentoalveolar Surgery (Tooth Extractions & Alveoloplasty). Its NAICS code is 339114 and its SIC code is 3843.